Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Pozycja w akcjach #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Cena akcji
$4.84
Kapitalizacja rynkowa
$633.18M
Zmiana (1 dzień)
3.20%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel Exscientia plc (EXAI)

Kategoria

Healthcare
Zyski dla Exscientia plc (EXAI)
Zyski w Sep 2024 TTM: $-207.65M
Według najnowszych raportów finansowych Exscientia plc, obecny zysk firmy wynosi $-207.65M. W roku 2022 firma osiągnęła zysk w wysokości $-167.36M, spadek w porównaniu do zysku z roku 2021, który wynosił $-56.36M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Exscientia plc od 2019 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-207.65M 0.64%
2023 $-206.34M 23.29%
2022 $-167.36M 196.95%
2021 $-56.36M 24.08%
2020 $-45.42M 224.78%
2019 $-13.99M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$20.46B -9,951.57%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -2,336.03%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -2,618.95%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -1,129.45%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -877.39%
AU